Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

News Conference News

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

L.A. McKeown

November 18, 2022

News Conference News VIVA 2022

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

L.A. McKeown

November 04, 2022

News Conference News VIVA 2022

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

L.A. McKeown

November 03, 2022

News Conference News AHA 2022

Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link

L.A. McKeown

November 01, 2022

Presentation TCT 2022

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Presenter: Marc Bonaca

September 17, 2022

News Daily News

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

Michael O'Riordan

September 09, 2022

News Opinion CV Team Dispatch

September 2022 News Roundup

L.A. McKeown

September 01, 2022

News Conference News ESC 2022

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

L.A. McKeown

August 30, 2022

News Conference News ESC 2022

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

L.A. McKeown

August 26, 2022

News Daily News

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

L.A. McKeown

August 05, 2022

News Daily News

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

Yael L. Maxwell

August 03, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Daily News

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

L.A. McKeown

June 23, 2022

News Daily News

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

L.A. McKeown

June 01, 2022

News Conference News EAS 2022

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Michael O'Riordan

May 24, 2022

News Daily News

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Michael O'Riordan

May 09, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Daily News

SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement

L.A. McKeown

April 27, 2022

Advertisement

December 2022 News Roundup

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices

‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups

TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years

Atrial Fibrosis Mediated by Gum Disease May Be Missing AF Link

Medical Therapy for PAD: PCSK9, SGLT2, Anticoagulation and Beyond

Exercise Keeps Athletic Heart Supple, Strong, Healthy: JACC Deep Dive

September 2022 News Roundup

DANCAVAS: Food for Thought as CV Screening in Older Men Misses Mark

First Cardio-Oncology Guidelines From ESC Cover ‘Tremendous’ Territory

IVUS Useful in Many Peripheral Intervention Scenarios, Consensus Document

Meat Consumption and Gut Microbiome Linked to ASCVD Risk

High Lp(a) May Predict Risk of CV and Limb Events in PAD

Comorbidities May Drive PAD Procedural Outcomes in Black Patients

Five-Year Paclitaxel DCB Data Attest to Long-term Safety, Efficacy

Stepwise or Hammer Down? Experts Debate Best Approach to LDL-Lowering

Mediterranean Diet Bests Low Fat for Secondary Prevention: CORDIOPREV

Good News and Bad for High-Intensity Statin Use in ASCVD

SCAI-Led Position Statement on CLTI Spotlights Multispeciality Involvement

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content